| Authors: |
Lecker LSM; Barts Cancer Institute, London, United Kingdom., Berlato C; Barts Cancer Institute, London, United Kingdom., Maniati E; Barts Cancer Institute, London, United Kingdom., Delaine-Smith R; Barts Cancer Institute, London, United Kingdom., Pearce OMT; Barts Cancer Institute, London, United Kingdom., Heath O; Barts Cancer Institute, London, United Kingdom., Nichols SJ; Barts Cancer Institute, London, United Kingdom., Trevisan C; Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.; Department of Women and Children Health, University of Padova, Padova, Italy., Novak M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., McDermott J; Barts Cancer Institute, London, United Kingdom., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Cutillas PR; Barts Cancer Institute, London, United Kingdom., Rajeeve V; Barts Cancer Institute, London, United Kingdom., Hennino A; Cancer Research Center of Lyon, UMR INSERM 1052, Lyon, France., Drapkin R; Ovarian Cancer Research Center, Perelman School of Medicine, Philadelphia, Pennsylvania., Loessner D; Barts Cancer Institute, London, United Kingdom., Balkwill FR; Barts Cancer Institute, London, United Kingdom. f.balkwill@qmul.ac.uk. |
